An Integrated Telemedicine-Home Visitation Program to Increase Outcomes for Children With Medical Complexity
NCT ID: NCT03590509
Last Updated: 2020-10-14
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Clinical Phase
NA
Total Enrollment
422 participants
Study Classification
INTERVENTIONAL
Study Start Date
2018-08-23
Study Completion Date
2020-05-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Children with medical complexity (CMC) account for \<1% of all children but approximately 40% of all pediatric deaths and inpatient care spending in the U.S.1 Optimizing their outcomes requires a comprehensive approach to augmenting care in all settings: clinic, hospital, and home. The clinic component of the comprehensive care (CC) program provides 24/7 access to an experienced team of primary care providers and subspecialists and reduced their serious illnesses and hospital and ICU days by 47-69% and health-system costs by \>$10,000 per child-year.2,3 The hospital component (inpatient consultation service) is further improving outcomes. Having improved both inpatient and outpatient care, the investigators now propose to complete a 360 degree approach by developing and rigorously assessing an integrated telemedicine-home-visitation program (THVP) to augment care for CMC in their homes to reduce the need for clinic visits as well hospitalizations. Building on prior experience in using telemedicine for children at UTH and evidence of benefits in other populations, 4,5 the providers will use a convenient, inexpensive, HIPAA-compliant telemedicine platform to make observations in the home to augment care, help address acute problems remotely at any hour, better coordinate care with healthcare personnel, and thereby reduce clinic visits, ED visits, and hospitalizations. Home visits will be conducted by a nurse home visitor whenever considered likely to be beneficial for any of the CMC and at least once by the primary care providers (PCPs) immediately following enrollment of children with chronic respiratory failure requiring mechanical ventilation at home. To promote reimbursements and further grant funding, the investigators will test the integrated THVP in a randomized quality improvement (QI) pilot study to verify its effectiveness in reducing total days of care outside the home.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home
NCT02870387
Chronic Illnesses
COMPLETED
NA
Self-management Intervention for Children With Chronic Medical Complexity: Pilot Feasibility Trial
NCT04470193
Children With Medical Complexity
COMPLETED
NA
Paediatric Resident Complex Care Curriculum RCT
NCT03349541
Complex Care
Medical Education
Pediatric Residents
+1 more
COMPLETED
NA
Discharge to Home and Chronic Illness Care Pilot
NCT02165423
Solid Organ Transplant
COMPLETED
NA
Comprehensive Care of Children With Medical Complexity
NCT01834456
Quality of Life
Chronic Disease
Chronic Illness
COMPLETED
NA
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background Children with medical complexity (CMC) have one or more chronic illnesses, require treatment from multiple specialists, and often depend on medical technology for respiratory and nutritional support.6 Their care is fragmented, ineffective, and inefficient,2,7 and while they represent only 0.4% of all children in the US, they account for approximately 40% of pediatric deaths and hospital charges.6
Optimizing their outcomes is likely to require a comprehensive approach to their care in all settings: clinic, hospital, and home. The investigators have developed effective programs for their clinic and hospital care and now propose to add an innovative program to improve care in the home and verify its incremental cost effectiveness.
The clinic component is provided in the High-Risk Children's Clinic (HRCC), an enhanced medial home for CMC staffed by a highly experienced team of nurse practitioners, pediatricians, and pediatric subspecialists. The multiple features to promote prompt effective care at all hours include 24/7 cell-phone access to the PCPs. As shown in the prior randomized trial (funded by a CMS Health Care Innovation Award), this program reduced ED visits, hospital days, and ICU days by 47-69%, and health system costs by $10,258 per child-year below that with usual care. This trial was published in JAMA,2 highlighted by CMS, and attracted national attention as the most rigorous evidence to date supporting medical homes for patient group.8,9 The remarkable cost effectiveness of this program was found in later cohort analyses to have been well maintained or enhanced when the program was expanded to include all eligible CMC, including prior control children and new enrollees.3
The hospital component is an inpatient consultation service in which the HRCC staff consult and follow their patients admitted to Children's Memorial Hermann Hospital (CMHH) to make treatment recommendations, coordinate care, and plan their discharge. The investigators randomized half of HRCC patients to receive this service in pilot testing. Results indicate a major reduction in inpatient days for patients given the service vs. those not given the service: 289 vs. 615 total hospital days/100 child-years with a 95% (posterior) probability of reduced hospital days in Bayesian analysis (rate ratio \[RR\], 0.62 \[0.36, 1.09\]). Having improved both inpatient and outpatient care, the investigators now propose to develop and rigorously assess a novel integrated telemedicine-home-visitation program (THVP) to also augment care for CMC in their home. The investigators will test the program in a clinical trial to verify its effectiveness and cost-effectiveness in reducing total days of care outside the home and to augment clinical practice and health policy.
Rationale and Evidence Base
As emphasized by Hoffman and Emanuel10:
"Clinicians need to abandon their long-established approach of caring for patients in the hospital or the office…Patients spend most of their time away from the health care system and the focus has to be one of managing their health literally where they live with much more wireless monitoring, electronic and phone visits, at-home care, and patient engagement."
Reducing the need for care outside the home is likely to be especially beneficial for CMC; \>90% are Medicaid beneficiaries. Their parents have limited resources and many find it difficult or costly to miss work and travel to Texas Medical Center. Moreover, any time spent in a medical setting imposes a risk of acquiring serious, even life-threating infections for CMC.
A systematic review by AHRQ in 201611 reported that: 1) telemedicine promotes positive outcomes for chronically ill adults but has received little study for CMC, and 2) research to identify cost-effective models of telehealth deserves high priority.
Home visits have been widely recommended to improve care and reduce clinic visits and hospitalizations.12-15 However, systematic reviews of home visitation have emphasized the need for further study, particularly for socially high-risk children.13
To maximize the potential benefits, the investigators will provide both interventions in an integrated program. The investigators will randomize the CMC in the HRCC to receive either the usual complex care (UCC \[including comprehensive outpatient care and inpatient consultation\] or THVP (UCC plus this telemedicine-home-visitation program)
Study Hypotheses
Primary Hypothesis: THVP will reduce days of care outside the home (in the hospital, ED, or clinic \[excluding well-child checks\]).
Secondary Hypotheses:
1. THVP will reduce the rate of serious illness (death, PICU admission, or prolonged hospitalization \>7 days);
2. THVP will reduce the total number of ER visits;
3. THVP will reduce the total number of admissions;
4. THVP will reduce the total number of PICU admission
5. THVP will reduce the total number of readmissions within 30 days of discharge;
6. THVP will reduce health system costs;
7. THVP will not reduce the total number of well-child checks;
8. THVP will increase maternal rating on pre-selected questions of The Consumer Assessment of Healthcare Providers and Systems (CAHPS) Child 12-Month Survey;
Methods
Enrollment and Randomization: The UTH institutional review board has reviewed this study and determined that it does not qualify as human subject research. As a result, the study was registered within the UTH QI Project database. Partly because of differences in the number of routine visits, all eligible CMC will be stratified by age (\< 2 years or older), and by estimated baseline risk (risk level 1 \[mechanical ventilation\], risk level 2 \[equal to or above the expected median risk but not ventilator-dependent\], and risk level 3 \[below the expected median risk\]), as judged by the clinic's medical director \[R. Mosquera\] based on patient's diagnoses, prior clinical course, current medical status, and socioeconomic risk factors. Patients will be randomized to either THVP or UCC using a computer-generated algorithm in REDCap with variable block sizes. Randomization will occur at baseline for the existing HRCC patients, before hospital discharge for newly enrolled patients with chronic respiratory failure requiring mechanical ventilation at home, and during the first clinic visit for any eligible new non-ventilator dependent children. Patient enrollment will occur between July 2018 and June 2020.
Integrated Telemedicine-Home-Visitation Program
The program is based on: 1) published findings of telemedicine or home visits in chronically ill children with diabetes, hemophilia, or leukemia;5,13-15 2) the collaboration with Drs. Harting and Mary Austin in successfully using telemedicine for postoperative follow-up visits for approximately 40 children in the past 14 months; 3) consultation from IT personnel at both MHH (Brian Thyer, Lead Programmer Analyst), and UTH (Andrew Streckfuss, MBA, Manager of IT Projects and Research) who have setup Zoom platform at UTH. In refining the program during the project, the investigators expect to interact with centers advancing telemedicine use for children with asthma, diabetes, hemophilia, or leukemia.4,5
Planned Telemedicine Features: The investigators will use the Zoom platform for telemedicine. Because the clinic is already equipped with a smart television, web cameras, and an emergency IPhone, no additional equipment will be required. With the help of HRCC staff, the families randomized to THVP will download a free Zoom application to any Android or iPhone, which almost all the patients already have. Telemedicine will be utilized systematically following calls received by the PCPs during clinic hours from parents seeking medical advice or trying to schedule same-day appointments for their sick child and only when considered likely to be beneficial for phone calls to the HRCC cell phone on weeknights and weekends. It will also be used for scheduled follow-up appointments as judged needed by the PCPs.
Home Visitation Features: Home visits will be conducted by a nurse home visitor when considered likely to be beneficial for any of the CMC and at least once by the assigned PCP shortly after discharge home from the hospital following enrollment of a ventilator-dependent child. Visits will be scheduled at a time convenient for the family. When needed for clinical or safety concerns, the nurse visitor or the PCP will be joined by a respiratory therapist, dietician, social worker, or medical assistant. Home visits will not be conducted whenever the visitor(s) feel unsafe. In these circumstances, the investigators will rely instead on telemedicine.
Blinding: While the families and HRCC staff cannot be blinded, the healthcare economist and the statistician will remain blinded to treatment group when performing the analyses.
Economic Evaluation and Statistical Analyses: The incremental costs of THVP vs. UCC will be assessed from a health system perspective. Inpatient costs will be based on hospital charges multiplied by MHH department-specific cost-to-charge ratios. The personnel time for providing office visits at the HRCC will be assessed by time motion studies and will be multiplied by personnel unit costs and the observed number of HRCC visits occurring in each treatment group during the study. The personnel time cost devoted to providing inpatient consultation will be assessed by multiplying the mean time spent on hospital consultations by the number of hospital days at CMHH occurring in each treatment group and by personnel unit costs. For the THVP group, the investigators will add the time spent providing telemedicine consultation by tabulating data on overall Zoom usage and multiplying it by personnel unit costs. THVP costs will also be augmented by the monthly fees for the Zoom licenses, and the HRCC staff time spent assisting patients with Zoom App installation and use. The remaining clinic costs for compressive care will be estimated based on the HRCC's total expenditures (including personnel salary, benefits, and overhead costs) and will be allocated to patients based on each patient length of follow-up during the study.
All economic and statistical analyses will be conducted using multilevel generalized estimating equation (GEE) models. Number of days of care in a medical setting in the THVP and UCC groups will be compared using a negative binomial GEE model with log link. Differences in costs between treatment groups will be assessed using a GEE model with log-link and gamma distribution. All the models will be adjusted for age (\< 2 years or older), baseline risk (risk levels 1,2, or 3), within-family correlation, length of follow-up, and any important differences in treatment with inpatient consultation.
The investigators will perform Bayesian analyses to assess the effectiveness of the THVP in reducing treatment days outside the home relative to UCC (primary outcome) using a neutral prior probability. Given the favorable prior evidence of benefit from THVP in other conditions,4,11 a skeptical prior is considered unnecessary. Based on the current number of patients and enrollment rates in the HRCC, the investigators expect to randomize \~400 patients during the 2-year study for a total of \~800 child-years of follow-up. THVP will be considered beneficial if: a) Bayesian analyses indicate it has a \>70% probability of reducing treatment days outside the home; and b) there is no evidence of an increase in adverse secondary outcomes. If so, provision of THVP could be recommended simply to increase access to care for vulnerable, disadvantaged children.
Optimizing their outcomes is likely to require a comprehensive approach to their care in all settings: clinic, hospital, and home. The investigators have developed effective programs for their clinic and hospital care and now propose to add an innovative program to improve care in the home and verify its incremental cost effectiveness.
The clinic component is provided in the High-Risk Children's Clinic (HRCC), an enhanced medial home for CMC staffed by a highly experienced team of nurse practitioners, pediatricians, and pediatric subspecialists. The multiple features to promote prompt effective care at all hours include 24/7 cell-phone access to the PCPs. As shown in the prior randomized trial (funded by a CMS Health Care Innovation Award), this program reduced ED visits, hospital days, and ICU days by 47-69%, and health system costs by $10,258 per child-year below that with usual care. This trial was published in JAMA,2 highlighted by CMS, and attracted national attention as the most rigorous evidence to date supporting medical homes for patient group.8,9 The remarkable cost effectiveness of this program was found in later cohort analyses to have been well maintained or enhanced when the program was expanded to include all eligible CMC, including prior control children and new enrollees.3
The hospital component is an inpatient consultation service in which the HRCC staff consult and follow their patients admitted to Children's Memorial Hermann Hospital (CMHH) to make treatment recommendations, coordinate care, and plan their discharge. The investigators randomized half of HRCC patients to receive this service in pilot testing. Results indicate a major reduction in inpatient days for patients given the service vs. those not given the service: 289 vs. 615 total hospital days/100 child-years with a 95% (posterior) probability of reduced hospital days in Bayesian analysis (rate ratio \[RR\], 0.62 \[0.36, 1.09\]). Having improved both inpatient and outpatient care, the investigators now propose to develop and rigorously assess a novel integrated telemedicine-home-visitation program (THVP) to also augment care for CMC in their home. The investigators will test the program in a clinical trial to verify its effectiveness and cost-effectiveness in reducing total days of care outside the home and to augment clinical practice and health policy.
Rationale and Evidence Base
As emphasized by Hoffman and Emanuel10:
"Clinicians need to abandon their long-established approach of caring for patients in the hospital or the office…Patients spend most of their time away from the health care system and the focus has to be one of managing their health literally where they live with much more wireless monitoring, electronic and phone visits, at-home care, and patient engagement."
Reducing the need for care outside the home is likely to be especially beneficial for CMC; \>90% are Medicaid beneficiaries. Their parents have limited resources and many find it difficult or costly to miss work and travel to Texas Medical Center. Moreover, any time spent in a medical setting imposes a risk of acquiring serious, even life-threating infections for CMC.
A systematic review by AHRQ in 201611 reported that: 1) telemedicine promotes positive outcomes for chronically ill adults but has received little study for CMC, and 2) research to identify cost-effective models of telehealth deserves high priority.
Home visits have been widely recommended to improve care and reduce clinic visits and hospitalizations.12-15 However, systematic reviews of home visitation have emphasized the need for further study, particularly for socially high-risk children.13
To maximize the potential benefits, the investigators will provide both interventions in an integrated program. The investigators will randomize the CMC in the HRCC to receive either the usual complex care (UCC \[including comprehensive outpatient care and inpatient consultation\] or THVP (UCC plus this telemedicine-home-visitation program)
Study Hypotheses
Primary Hypothesis: THVP will reduce days of care outside the home (in the hospital, ED, or clinic \[excluding well-child checks\]).
Secondary Hypotheses:
1. THVP will reduce the rate of serious illness (death, PICU admission, or prolonged hospitalization \>7 days);
2. THVP will reduce the total number of ER visits;
3. THVP will reduce the total number of admissions;
4. THVP will reduce the total number of PICU admission
5. THVP will reduce the total number of readmissions within 30 days of discharge;
6. THVP will reduce health system costs;
7. THVP will not reduce the total number of well-child checks;
8. THVP will increase maternal rating on pre-selected questions of The Consumer Assessment of Healthcare Providers and Systems (CAHPS) Child 12-Month Survey;
Methods
Enrollment and Randomization: The UTH institutional review board has reviewed this study and determined that it does not qualify as human subject research. As a result, the study was registered within the UTH QI Project database. Partly because of differences in the number of routine visits, all eligible CMC will be stratified by age (\< 2 years or older), and by estimated baseline risk (risk level 1 \[mechanical ventilation\], risk level 2 \[equal to or above the expected median risk but not ventilator-dependent\], and risk level 3 \[below the expected median risk\]), as judged by the clinic's medical director \[R. Mosquera\] based on patient's diagnoses, prior clinical course, current medical status, and socioeconomic risk factors. Patients will be randomized to either THVP or UCC using a computer-generated algorithm in REDCap with variable block sizes. Randomization will occur at baseline for the existing HRCC patients, before hospital discharge for newly enrolled patients with chronic respiratory failure requiring mechanical ventilation at home, and during the first clinic visit for any eligible new non-ventilator dependent children. Patient enrollment will occur between July 2018 and June 2020.
Integrated Telemedicine-Home-Visitation Program
The program is based on: 1) published findings of telemedicine or home visits in chronically ill children with diabetes, hemophilia, or leukemia;5,13-15 2) the collaboration with Drs. Harting and Mary Austin in successfully using telemedicine for postoperative follow-up visits for approximately 40 children in the past 14 months; 3) consultation from IT personnel at both MHH (Brian Thyer, Lead Programmer Analyst), and UTH (Andrew Streckfuss, MBA, Manager of IT Projects and Research) who have setup Zoom platform at UTH. In refining the program during the project, the investigators expect to interact with centers advancing telemedicine use for children with asthma, diabetes, hemophilia, or leukemia.4,5
Planned Telemedicine Features: The investigators will use the Zoom platform for telemedicine. Because the clinic is already equipped with a smart television, web cameras, and an emergency IPhone, no additional equipment will be required. With the help of HRCC staff, the families randomized to THVP will download a free Zoom application to any Android or iPhone, which almost all the patients already have. Telemedicine will be utilized systematically following calls received by the PCPs during clinic hours from parents seeking medical advice or trying to schedule same-day appointments for their sick child and only when considered likely to be beneficial for phone calls to the HRCC cell phone on weeknights and weekends. It will also be used for scheduled follow-up appointments as judged needed by the PCPs.
Home Visitation Features: Home visits will be conducted by a nurse home visitor when considered likely to be beneficial for any of the CMC and at least once by the assigned PCP shortly after discharge home from the hospital following enrollment of a ventilator-dependent child. Visits will be scheduled at a time convenient for the family. When needed for clinical or safety concerns, the nurse visitor or the PCP will be joined by a respiratory therapist, dietician, social worker, or medical assistant. Home visits will not be conducted whenever the visitor(s) feel unsafe. In these circumstances, the investigators will rely instead on telemedicine.
Blinding: While the families and HRCC staff cannot be blinded, the healthcare economist and the statistician will remain blinded to treatment group when performing the analyses.
Economic Evaluation and Statistical Analyses: The incremental costs of THVP vs. UCC will be assessed from a health system perspective. Inpatient costs will be based on hospital charges multiplied by MHH department-specific cost-to-charge ratios. The personnel time for providing office visits at the HRCC will be assessed by time motion studies and will be multiplied by personnel unit costs and the observed number of HRCC visits occurring in each treatment group during the study. The personnel time cost devoted to providing inpatient consultation will be assessed by multiplying the mean time spent on hospital consultations by the number of hospital days at CMHH occurring in each treatment group and by personnel unit costs. For the THVP group, the investigators will add the time spent providing telemedicine consultation by tabulating data on overall Zoom usage and multiplying it by personnel unit costs. THVP costs will also be augmented by the monthly fees for the Zoom licenses, and the HRCC staff time spent assisting patients with Zoom App installation and use. The remaining clinic costs for compressive care will be estimated based on the HRCC's total expenditures (including personnel salary, benefits, and overhead costs) and will be allocated to patients based on each patient length of follow-up during the study.
All economic and statistical analyses will be conducted using multilevel generalized estimating equation (GEE) models. Number of days of care in a medical setting in the THVP and UCC groups will be compared using a negative binomial GEE model with log link. Differences in costs between treatment groups will be assessed using a GEE model with log-link and gamma distribution. All the models will be adjusted for age (\< 2 years or older), baseline risk (risk levels 1,2, or 3), within-family correlation, length of follow-up, and any important differences in treatment with inpatient consultation.
The investigators will perform Bayesian analyses to assess the effectiveness of the THVP in reducing treatment days outside the home relative to UCC (primary outcome) using a neutral prior probability. Given the favorable prior evidence of benefit from THVP in other conditions,4,11 a skeptical prior is considered unnecessary. Based on the current number of patients and enrollment rates in the HRCC, the investigators expect to randomize \~400 patients during the 2-year study for a total of \~800 child-years of follow-up. THVP will be considered beneficial if: a) Bayesian analyses indicate it has a \>70% probability of reducing treatment days outside the home; and b) there is no evidence of an increase in adverse secondary outcomes. If so, provision of THVP could be recommended simply to increase access to care for vulnerable, disadvantaged children.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Chronic Disease
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Allocation Method
RANDOMIZED
Intervention Model
PARALLEL
Randomized Quality-Improvement Trial
Primary Study Purpose
HEALTH_SERVICES_RESEARCH
Blinding Strategy
SINGLE
Investigators
While the families and HRCC staff cannot be blinded, the healthcare economist and the statistician will remain blinded to treatment group when performing the analyses.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemedicine Program*
Integrated Telemedicine-Home Visitation\* Program.
\*After the approval of the study protocol, the home-visitation component of the integrated intervention was deemed not to be feasible with the available resources and personnel and has was not implemented
Group Type
EXPERIMENTAL
Telemedicine Program
Intervention Type
OTHER
A telemedicine platform (Zoom) will be added to comprehensive care (CC) to be used by the CC providers to make observations in the home to augment care, help address acute problems remotely at any hour, better coordinate care with healthcare personnel, and thereby reduce clinic visits, ED visits, and hospitalizations. Home visits\* will be conducted by a nurse home visitor whenever considered likely to be beneficial for any of the CMC and at least once by the assigned CC provider immediately following enrollment of children with chronic respiratory failure requiring mechanical ventilation at home.
\*After the approval of the study protocol, the home-visitation component of the integrated intervention was deemed not to be feasible with the available resources and personnel and has was not implemented
Control
Usual Comprehensive Care
Group Type
ACTIVE_COMPARATOR
Usual Comprehensive Care
Intervention Type
OTHER
Comprehensive care (CC) provided in an enhanced medical home to assure effective care at any hour for or children with medical complexity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemedicine Program
A telemedicine platform (Zoom) will be added to comprehensive care (CC) to be used by the CC providers to make observations in the home to augment care, help address acute problems remotely at any hour, better coordinate care with healthcare personnel, and thereby reduce clinic visits, ED visits, and hospitalizations. Home visits\* will be conducted by a nurse home visitor whenever considered likely to be beneficial for any of the CMC and at least once by the assigned CC provider immediately following enrollment of children with chronic respiratory failure requiring mechanical ventilation at home.
\*After the approval of the study protocol, the home-visitation component of the integrated intervention was deemed not to be feasible with the available resources and personnel and has was not implemented
Intervention Type
OTHER
Usual Comprehensive Care
Comprehensive care (CC) provided in an enhanced medical home to assure effective care at any hour for or children with medical complexity
Intervention Type
OTHER
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Integrated Telemedicine-Home Visitation* Program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children attending the High-Risk Children's Clinic
* 1 or more chronic conditions
* High healthcare utilization in the year prior to enrollment (of ≥3 ED visits, ≥2 hospitalizations, or ≥1 pediatric ICU admissions)
* \>50% estimated risk of hospitalization in the year after enrollment (as judged by Program's Director \[Dr. R. Mosquera\] based on patient's diagnosis, clinical course, and socioeconomic risk factor).
* 1 or more chronic conditions
* High healthcare utilization in the year prior to enrollment (of ≥3 ED visits, ≥2 hospitalizations, or ≥1 pediatric ICU admissions)
* \>50% estimated risk of hospitalization in the year after enrollment (as judged by Program's Director \[Dr. R. Mosquera\] based on patient's diagnosis, clinical course, and socioeconomic risk factor).
Exclusion Criteria
* Unrepaired congenital heart disease
* Mitochondrial disorders
* Active cancer
* Do-Not-Resuscitate (DNR) order
* Patients receiving compassionate care
* No Internet access
* Mitochondrial disorders
* Active cancer
* Do-Not-Resuscitate (DNR) order
* Patients receiving compassionate care
* No Internet access
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Texas Medical Center Health Policy Institute
UNKNOWN
Sponsor Role
collaborator
The University of Texas Health Science Center, Houston
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elenir BC Avritscher
Assistant Professor
Responsibility Role
PRINCIPAL_INVESTIGATOR
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elenir Avritscher
Role: PRINCIPAL_INVESTIGATOR
The University of Texas McGovern Medical School at Houston
Ricardo Mosquera, MD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas McGovern Medical School at Houston
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science, Houston
Houston, Texas, United States
Site Status
Countries
Review the countries where the study has at least one active or historical site.
United States
References
Explore related publications, articles, or registry entries linked to this study.
Simon TD, Berry J, Feudtner C, Stone BL, Sheng X, Bratton SL, Dean JM, Srivastava R. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010 Oct;126(4):647-55. doi: 10.1542/peds.2009-3266. Epub 2010 Sep 20.
Reference Type
BACKGROUND
Mosquera RA, Avritscher EB, Samuels CL, Harris TS, Pedroza C, Evans P, Navarro F, Wootton SH, Pacheco S, Clifton G, Moody S, Franzini L, Zupancic J, Tyson JE. Effect of an enhanced medical home on serious illness and cost of care among high-risk children with chronic illness: a randomized clinical trial. JAMA. 2014 Dec 24-31;312(24):2640-8. doi: 10.1001/jama.2014.16419.
Reference Type
BACKGROUND
Avritscher EBC, Mosquera RA, Samuels CL, et al. An Enhanced Medical Home for High-Risk Chronically Ill Children: Are Benefits Identified During a Clinical Trial Sustained in Practice? Under Review.
Reference Type
BACKGROUND
McLean S, Chandler D, Nurmatov U, Liu J, Pagliari C, Car J, Sheikh A. Telehealthcare for asthma. Cochrane Database Syst Rev. 2010 Oct 6;2010(10):CD007717. doi: 10.1002/14651858.CD007717.pub2.
Reference Type
BACKGROUND
Looman WS, Antolick M, Cady RG, Lunos SA, Garwick AE, Finkelstein SM. Effects of a Telehealth Care Coordination Intervention on Perceptions of Health Care by Caregivers of Children With Medical Complexity: A Randomized Controlled Trial. J Pediatr Health Care. 2015 Jul-Aug;29(4):352-63. doi: 10.1016/j.pedhc.2015.01.007. Epub 2015 Mar 5.
Reference Type
BACKGROUND
Simmonds B, Turner N, Thomas L, Campbell J, Lewis G, Wiles N, Turner K. Patients' experiences of participating in a large-scale trial of cognitive behavioural therapy for depression: a mixed methods study. Fam Pract. 2013 Dec;30(6):705-11. doi: 10.1093/fampra/cmt028. Epub 2013 Jul 12.
Reference Type
BACKGROUND
Kuo DZ, Cohen E, Agrawal R, Berry JG, Casey PH. A national profile of caregiver challenges among more medically complex children with special health care needs. Arch Pediatr Adolesc Med. 2011 Nov;165(11):1020-6. doi: 10.1001/archpediatrics.2011.172.
Reference Type
BACKGROUND
Cohen E, Berry JG, Camacho X, Anderson G, Wodchis W, Guttmann A. Patterns and costs of health care use of children with medical complexity. Pediatrics. 2012 Dec;130(6):e1463-70. doi: 10.1542/peds.2012-0175. Epub 2012 Nov 26.
Reference Type
BACKGROUND
Homer CJ, Klatka K, Romm D, Kuhlthau K, Bloom S, Newacheck P, Van Cleave J, Perrin JM. A review of the evidence for the medical home for children with special health care needs. Pediatrics. 2008 Oct;122(4):e922-37. doi: 10.1542/peds.2007-3762.
Reference Type
BACKGROUND
Hoffman A, Emanuel EJ. Reengineering US health care. JAMA. 2013 Feb 20;309(7):661-2. doi: 10.1001/jama.2012.214571. No abstract available.
Reference Type
BACKGROUND
Totten AM, Womack DM, Eden KB, McDonagh MS, Griffin JC, Grusing S, Hersh WR. Telehealth: Mapping the Evidence for Patient Outcomes From Systematic Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jun. Report No.: 16-EHC034-EF. Available from http://www.ncbi.nlm.nih.gov/books/NBK379320/
Reference Type
BACKGROUND
Wells S, O'Neill M, Rogers J, Blaine K, Hoffman A, McBride S, Tschudy MM, Shumskiy I, Mauskar S, Berry JG. Nursing-led Home Visits Post-hospitalization for Children with Medical Complexity. J Pediatr Nurs. 2017 May-Jun;34:10-16. doi: 10.1016/j.pedn.2017.03.003. Epub 2017 Mar 23.
Reference Type
BACKGROUND
Peacock S, Konrad S, Watson E, Nickel D, Muhajarine N. Effectiveness of home visiting programs on child outcomes: a systematic review. BMC Public Health. 2013 Jan 9;13:17. doi: 10.1186/1471-2458-13-17.
Reference Type
BACKGROUND
Parab CS, Cooper C, Woolfenden S, Piper SM. Specialist home-based nursing services for children with acute and chronic illnesses. Cochrane Database Syst Rev. 2013 Jun 15;2013(6):CD004383. doi: 10.1002/14651858.CD004383.pub3.
Reference Type
BACKGROUND
Cooper C, Wheeler DM, Woolfenden SR, Boss T, Piper S. Specialist home-based nursing services for children with acute and chronic illnesses. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004383. doi: 10.1002/14651858.CD004383.pub2.
Reference Type
BACKGROUND
Mosquera RA, Avritscher EBC, Pedroza C, Lee KH, Ramanathan S, Harris TS, Eapen JC, Yadav A, Caldas-Vasquez M, Poe M, Martinez Castillo DJ, Harting MT, Ottosen MJ, Gonzalez T, Tyson JE. Telemedicine for Children With Medical Complexity: A Randomized Clinical Trial. Pediatrics. 2021 Sep;148(3):e2021050400. doi: 10.1542/peds.2021-050400.
Reference Type
DERIVED
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02-25769000-33200-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
A Pilot Clinical Trial to Determine the Feasibility of Administering an Electronic Tool to Assess Postoperative pAin, Nausea, and Vomiting in English or Spanish-Speaking Pediatric Patients With Neoplastic Conditions.
NCT05933252
COMPLETED
NA
E-PRIME For Children With Medical Complexity
NCT06216548
RECRUITING
NA
Digital-storytelling Intervention for Rural-dwelling Children
NCT04665479
COMPLETED
NA
Educational Eczema Video Intervention
NCT03664271
NOT_YET_RECRUITING
NA
Parent Tube Weaning Interviews
NCT07054983
ENROLLING_BY_INVITATION
NA
Starzl Network Patient Reported Outcomes
NCT05241847
COMPLETED
NA
Efficacy of Audio Recorded Guided Imagery vs Deep Breathing Exercises on Functional Gastrointestinal Pain Disorders
NCT03100487
COMPLETED
NA
App-based Consent for Pediatric Clinical Research
NCT05880147
COMPLETED
NA
CHAMP For the Feeder: Tube Feeding Study
NCT06052891
ENROLLING_BY_INVITATION
Complexity in Health, Education, and Social Support for Children and Young People With Life-limiting Conditions.
NCT07102433
NOT_YET_RECRUITING
Multi-institutional Trial of Non-operative Management of Appendicitis
NCT02271932
UNKNOWN
Development and Validation of an Automated Measurement of Child Screen Media Use: FLASH
NCT03382951
COMPLETED
ECMO Hemostatic Transfusions in Children
NCT05796557
COMPLETED
PHASE4
Utility of Advanced Ultrasound Otoscope In The Diagnosis of AOM
NCT06429709
ACTIVE_NOT_RECRUITING
Assessment of an App Based on Artificial Intelligence for Purulent AOM Diagnosis in a Pediatric Department
NCT04752891
COMPLETED
NA
Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images
NCT04125095
ACTIVE_NOT_RECRUITING
The Feasibility, Acceptability and Clinical Utility of a New Remote-mobile Technology Intervention (ASARM) for CFS/ME in a Paediatric Population
NCT02082730
COMPLETED
NA
Use of a Patient Decision Aid for Gastrologic Endoscopy in a Pediatric Setting
NCT00813033
COMPLETED
NA
Impact of Aromatherapy on Nausea in Hospitalized Children Undergoing Rehabilitation
NCT06009211
ENROLLING_BY_INVITATION
Computer-Supported Management of Medical-Legal Issues Impacting Child Health
NCT01800669
COMPLETED
NA
Fast MR for Young Children With Traumatic Brain Injury
NCT02392975
COMPLETED
NA
Impact of a Telenursing Service on Satisfaction and Health Outcomes of Children With Inflammatory Rheumatic Diseases
NCT01511341
COMPLETED
NA
Optimizing Treatment to Improve TBM Outcomes in Children
NCT02958709
COMPLETED
PHASE1/PHASE2
Laser Acupuncture Against Nausea in Children
NCT00528554
UNKNOWN
NA
Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Children
NCT07222943
NOT_YET_RECRUITING
NA